The Challenge of Globalization for Large Chinese Firms |
| |
| Authors: | Peter Nolan Jin Zhang |
| |
| Affiliation: | 1. Assistant Professor, Oral and Maxillofacial Surgery, Oral, Head & Neck Oncology and Microvascular Surgery, The University of Texas Health Science Center at Houston, Houston, TX;2. Chief Resident, Oral and Maxillofacial Surgery, The University of Texas Health Science Center at Houston, Houston, TX;3. Third-Year Dental Student, School of Dentistry, The University of Texas Health Science Center at Houston, Houston, TX;4. Assistant Professor, Oral and Maxillofacial Surgery, Oral, Head & Neck Oncology and Microvascular Surgery, The University of Texas Health Science Center at Houston, Houston, TX;1. Department of Radiation Oncology, Sun Yat-sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre of Cancer Medicine, Guangzhou, People''s Republic of China;7. Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre of Cancer Medicine, Guangzhou, People''s Republic of China;11. Department of Medical Oncology, Sun Yat-sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre of Cancer Medicine, Guangzhou, People''s Republic of China;12. Clinical Trials Centre, Sun Yat-sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre of Cancer Medicine, Guangzhou, People''s Republic of China;2. Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, People''s Republic of China;3. Department of Medical Oncology, Antwerp University Hospital, Edegem, Belgium;4. Department of Radiation Oncology, National Cancer Centre Singapore, Singapore;6. Department of Radiation Oncology, University of Toronto; Ontario Cancer Institute, University Health Network, Toronto, Ontario, Canada;5. Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan;8. Department of Medical Statistics and Epidemiology, School of Public Health, Sun Yat-sen University, Guangzhou, People''s Republic of China;1. Department of Health Policy and Management, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA;2. The Cecil G. Sheps Center for Health Services Research, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA;3. Department of Epidemiology, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA;4. Optum, Eden Prairie, MN, USA;5. Duke Clinical Research Institute, Duke University, Durham, NC, USA |
| |
| Abstract: | ![]()
As China joins the World Trade Organization, the authors question whether China’s large firms will be able to compete on the global level playing field. Over the past two decades, Chinese large enterprises have undertaken extensive evolutionary change but, at the same time, the world’s leading firms have undergone a revolutionary transformation. Based on analysis of firms with the aerospace, oil and petrochemical industry, the authors conclude that China’s leading firms face critical challenges, even in sectors in which China’s policy-makers have scored significant successes. |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
